載入...
Patient and site characteristics associated with pirfenidone and nintedanib use in the United States; an analysis of idiopathic pulmonary fibrosis patients enrolled in the Pulmonary Fibrosis Foundation Patient Registry
BACKGROUND: Pragmatic use of the anti-fibrotic medications pirfenidone and nintedanib for idiopathic pulmonary fibrosis (IPF) in the United States (US) has not been studied and may be different from international settings due to structural differences between health care systems. This study examined...
Na minha lista:
| 發表在: | Respir Res |
|---|---|
| Main Authors: | , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
BioMed Central
2020
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7011239/ https://ncbi.nlm.nih.gov/pubmed/32041621 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12931-020-1315-4 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|